<DOC>
	<DOCNO>NCT02218242</DOCNO>
	<brief_summary>All patient undergo video-assisted thoracoscopic ( VATS ) resection lung cancer receive standard therapy include lobectomy sub-lobar resection mediastinal lymph node dissection . After completion standard care , intraoperative ultrasound use evaluate lymph node station presence miss lymph node particular focus lymph node may appear pathologic ultrasound evaluation . Data review rate pathologic upstaging , sensitivity specificity ultrasound additional diagnostic tool operate room evaluate . It hypothesize Intra-operative thoracoscopic ultrasound follow standard video-assisted thoracoscopic ( VATS ) dissection increase rate pathologically stag N2 node non-small cell lung cancer patient undergo definitive surgical resection .</brief_summary>
	<brief_title>Thoracoscopic Lung Cancer Staging With Use Intraoperative Ultrasound</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Age ≥18 year . ECOG performance status ≤2 ( Karnofsky ≥60 % , see Appendix A ) . Life expectancy great 3 month Patients able undergo VATS resection define : Preoperative FEV1 ≥ 40 % predict OR Postoperative predict FEV1 ≥ 0.8 l Hg ≥ 8.0 No evidence coronary ischemia stress evaluation Ability understand willingness sign write informed consent document . Patients surgery prior ipsilateral lung cancer Patients know brain metastasis Uncontrolled intercurrent illness include , limited , ongoing active infection , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , psychiatric illness/social situation would limit compliance study requirement . ( Patients HIV exclude study )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Lung</keyword>
	<keyword>Cancer</keyword>
	<keyword>Ultrasound</keyword>
	<keyword>Staging</keyword>
</DOC>